Relapsing Nasal Septal Leishmaniasis: Lessons in Long‐Term Multidisciplinary Management Case Report
Case Reports in Infectious Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/crdi/1784961 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Infectious Diseases, online erschienen am 17.06.2026. Verfasst von Emily Ehsan und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA, unmc.edu. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Mucosal leishmaniasis (ML) is a rare, destructive, and recurrent protozoal infection caused by Leishmania species, most commonly Leishmania braziliensis . ML can develop months to years after initial cutaneous leishmaniasis (CL) and may lead to severe mucosal destruction if untreated. Case Presentation We present a case of a 48‐year‐old healthy male from Venezuela with prior CL treated with intravenous meglumine antimoniate who subsequently developed progressive nasal symptoms consistent with ML. Initial therapy with oral fluconazole was ineffective, but treatment with miltefosine led to symptom resolution. The patient underwent four‐staged reconstructive surgeries with ENT. Thirty‐eight months later, the patient developed recurrent symptoms, and biopsy confirmed infection with L. braziliensis . He was subsequently treated with intravenous amphotericin B, which led to clinical improvement.
Discussion
This case highlights the relapsing nature of ML, its potential for extensive mucosal damage, and the importance of a structured, long‐term care plan. This case in particular is unique given the extended delay before recurrence following miltefosine therapy. The high recurrence rate of L. braziliensis infections underscores the importance of vigilant long‐term follow‐up and consideration of systemic therapy. Multidisciplinary management is often necessary to optimize outcomes.
Conclusion
Early recognition of ML, timely systemic therapy, structured multidisciplinary care, and adherence to a long‐term surveillance plan are critical to prevent mucosal destruction and manage relapses effectively. Extended surveillance may be warranted to detect late relapses in patients treated with newer or more effective agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA, unmc.edu.
- Department of Otolaryngology-Head and Neck Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA, unmc.edu.
- Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA, unmc.edu.
ORCID-Profile: Emily Ehsan
Zitieren
APA
Ehsan, E., Staab, E., Geelan-Hansen, K., & Hankins, R. (2026). Relapsing Nasal Septal Leishmaniasis: Lessons in Long‐Term Multidisciplinary Management Case Report. Case Reports in Infectious Diseases, 2026(1). https://doi.org/10.1155/crdi/1784961
Vancouver
Ehsan E, Staab E, Geelan-Hansen K, Hankins R. Relapsing Nasal Septal Leishmaniasis: Lessons in Long‐Term Multidisciplinary Management Case Report. Case Reports in Infectious Diseases. 2026;2026(1). doi:10.1155/crdi/1784961
BibTeX
@article{Ehsan2026,
author = {Ehsan, Emily and Staab, Ellie and Geelan-Hansen, Katie and Hankins, Richard},
title = {Relapsing Nasal Septal Leishmaniasis: Lessons in Long‐Term Multidisciplinary Management Case Report},
journal = {Case Reports in Infectious Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crdi/1784961}
}
EUVIMED